233 related articles for article (PubMed ID: 3358947)
1. Influence of the acyl-CoA: cholesterol O-acyltransferase inhibitor, CL 277082, on cholesteryl ester accumulation in rabbit macrophage-rich granulomas and hepatic tissue.
Kelley JL; Suenram CA; Rozek MM; Schaffer SA; Schwartz CJ
Biochim Biophys Acta; 1988 May; 960(1):83-90. PubMed ID: 3358947
[TBL] [Abstract][Full Text] [Related]
2. Effect of E5324, a novel inhibitor of acyl-CoA:cholesterol acyltransferase, on cholesteryl ester synthesis and accumulation in macrophages.
Kogushi M; Tanaka H; Kobayashi H; Yamada T; Ohtsuka I; Kimura T; Saito I
Jpn J Pharmacol; 1995 Jun; 68(2):191-9. PubMed ID: 7563976
[TBL] [Abstract][Full Text] [Related]
3. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages.
Graham A; Angell AD; Jepson CA; Yeaman SJ; Hassall DG
Atherosclerosis; 1996 Feb; 120(1-2):135-45. PubMed ID: 8645354
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation between ACAT mRNA expression and cholesterol esterification in primary liver cells.
Rea TJ; DeMattos RB; Homan R; Newton RS; Pape ME
Biochim Biophys Acta; 1996 Jan; 1299(1):67-74. PubMed ID: 8555254
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of acyl-CoA cholesterol O-acyltransferase reduces the cholesteryl ester enrichment of atherosclerotic lesions in the Yucatan micropig.
Bocan TM; Mueller SB; Uhlendorf PD; Brown EQ; Mazur MJ; Black AE
Atherosclerosis; 1993 Mar; 99(2):175-86. PubMed ID: 8503946
[TBL] [Abstract][Full Text] [Related]
6. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
[TBL] [Abstract][Full Text] [Related]
7. Evolution of foam cells in subcutaneous rabbit carrageenan granulomas. II. Tissue and macrophage lipid composition.
Kelley JL; Suenram CA; Valente AJ; Sprague EA; Rozek MM; Schwartz CJ
Am J Pathol; 1985 Sep; 120(3):391-401. PubMed ID: 4037066
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of oleate-rich cholesteryl esters by acetyl-LDL in macrophages in the presence of an acyl-CoA: cholesterol acyltransferase inhibitor (Sandoz 58-035).
Shimasaki O; Mineo C; Mowri H; Ohkuma S; Takano T
Biochem Int; 1990; 20(2):389-96. PubMed ID: 2317217
[TBL] [Abstract][Full Text] [Related]
9. On the mechanism by which an ACAT inhibitor (CL 277,082) influences plasma lipoproteins in the rat.
Balasubramaniam S; Simons LA; Chang S; Roach PD; Nestel PJ
Atherosclerosis; 1990 May; 82(1-2):1-5. PubMed ID: 2360913
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of acyl-CoA: cholesterol acyltransferase decreases apolipoprotein B-100-containing lipoprotein secretion from HepG2 cells.
Musanti R; Giorgini L; Lovisolo PP; Pirillo A; Chiari A; Ghiselli G
J Lipid Res; 1996 Jan; 37(1):1-14. PubMed ID: 8820097
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.
Graham A; Wood JL; Russell LJ
Biochim Biophys Acta; 1996 Jul; 1302(1):46-54. PubMed ID: 8695654
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of lipoxygenase products into cholesteryl esters by acyl-CoA:cholesterol acyltransferase in cholesterol-rich macrophages.
Mathur SN; Albright E; Field FJ
Biochem J; 1988 Dec; 256(3):807-14. PubMed ID: 3223954
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal macrophage cholesteryl ester content as a function of plasma cholesterol in rats.
Musanti R; Chiari A; Ghiselli G
Arterioscler Thromb; 1991; 11(4):1111-9. PubMed ID: 2065032
[TBL] [Abstract][Full Text] [Related]
14. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis.
Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD
Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence that the lipid-regulating activity of the ACAT inhibitor CI-976 in rats is due to inhibition of both intestinal and liver ACAT.
Krause BR; Anderson M; Bisgaier CL; Bocan T; Bousley R; DeHart P; Essenburg A; Hamelehle K; Homan R; Kieft K
J Lipid Res; 1993 Feb; 34(2):279-94. PubMed ID: 8429262
[TBL] [Abstract][Full Text] [Related]
16. Effects of acyl-CoA: cholesterol O-acyltransferase inhibition on cholesterol absorption and plasma lipoprotein composition in hamsters.
Schnitzer-Polokoff R; Compton D; Boykow G; Davis H; Burrier R
Comp Biochem Physiol A Comp Physiol; 1991; 99(4):665-70. PubMed ID: 1679704
[TBL] [Abstract][Full Text] [Related]
17. Cholesteryl ester metabolism in fat- and cholesterol/fat-fed guinea pigs.
Drevon CA
Atherosclerosis; 1978 Jun; 30(2):123-36. PubMed ID: 678314
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
[TBL] [Abstract][Full Text] [Related]
19. ACAT inhibition decreases LDL cholesterol in rabbits fed a cholesterol-free diet. Marked changes in LDL cholesterol without changes in LDL receptor mRNA abundance.
Krause BR; Pape ME; Kieft K; Auerbach B; Bisgaier CL; Homan R; Newton RS
Arterioscler Thromb; 1994 Apr; 14(4):598-604. PubMed ID: 8148358
[TBL] [Abstract][Full Text] [Related]
20. Importance of exogenous cholesterol in diabetic rats: effects of treatment with insulin or with an acyl-CoA:cholesterol acyltransferase inhibitor.
Maechler P; Wollheim CB; Bentzen CL; Niesor E
Ann Nutr Metab; 1993; 37(4):199-209. PubMed ID: 8215237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
